These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7349890)

  • 1. Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.
    Kirkwood JM; Ensminger W; Rosowsky A; Papathanasopoulos N; Frei E
    Cancer Res; 1980 Jan; 40(1):107-13. PubMed ID: 7349890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.
    Remick SC; Grem JL; Fischer PH; Tutsch KD; Alberti DB; Nieting LM; Tombes MB; Bruggink J; Willson JK; Trump DL
    Cancer Res; 1990 May; 50(9):2667-72. PubMed ID: 2328492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacologic effects of thymidine plus 5-FU.
    Ohnuma T; Roboz J; Waxman S; Mandel E; Martin DS; Holland JF
    Cancer Treat Rep; 1980; 64(12):1169-77. PubMed ID: 7471111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion.
    Chiuten DF; Wiernik PH; Zaharko DS; Edwards L
    Cancer Res; 1980 Mar; 40(3):818-22. PubMed ID: 7471098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response.
    Benz C; DeGregorio M; Saks S; Sambol N; Holleran W; Ignoffo R; Lewis B; Cadman E
    Cancer Res; 1985 Jul; 45(7):3354-8. PubMed ID: 4005858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of methotrexate toxicity by thymidine infusions in humans.
    Ensminger WD; Frei E
    Cancer Res; 1977 Jun; 37(6):1857-63. PubMed ID: 870189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine rescue of high-dose methotrexate in humans.
    Howell SB; Ensminger WD; Krishan A; Frei E
    Cancer Res; 1978 Feb; 38(2):325-30. PubMed ID: 637906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear pharmacokinetics of thymidine, thymine, and fluorouracil and their kinetic interactions in normal dogs.
    Covey JM; Straw JA
    Cancer Res; 1983 Oct; 43(10):4587-95. PubMed ID: 6883317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2).
    Joulia JM; Pinguet F; Ychou M; Duffour J; Topart D; Grosse PY; Astre C; Bressolle F
    Anticancer Res; 1997; 17(4A):2727-30. PubMed ID: 9252705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.
    Bruno S; Grindey G; Zakrzewski S; Priore R; Kinahan J; Moayeri H; Ledesma E; Mittelman A; Creaven P
    Cancer Res; 1982 Nov; 42(11):4824-6. PubMed ID: 6982097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.
    Blumenreich MS; Woodcock TM; Andreeff M; Hiddemann W; Chou TC; Vale K; O'Hehir M; Clarkson BD; Young CW
    Cancer Res; 1984 May; 44(5):2203-7. PubMed ID: 6713407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.
    Fraile RJ; Baker LH; Buroker TR; Horwitz J; Vaitkevicius VK
    Cancer Res; 1980 Jul; 40(7):2223-8. PubMed ID: 7388790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for continuous drug infusion in unrestrained rats: its application in evaluating the toxicity of 5-fluorouracil/thymidine combinations.
    Danhauser LL; Rustum YM
    J Lab Clin Med; 1979 Jun; 93(6):1047-53. PubMed ID: 438606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
    Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
    Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.